Stay updated on ABRAZO Clinical Trial
Sign up to get notified when there's something new on the ABRAZO Clinical Trial page.

Latest updates to the ABRAZO Clinical Trial page
- Check2 days agoChange DetectedAdded a consolidated Locations section listing site locations by region (California, Florida, Indiana, Maryland, New York, Tennessee, Texas, Bavaria, Rhineland-Palatinate, Saxony, England, Lancashire). Removed the HHS Vulnerability Disclosure footer link and updated the page revision tag to v3.3.3.SummaryDifference0.9%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedMinor textual updates were made to the Publications section: an added note that publications are automatically filled from PubMed and a new Revision: v3.3.1, and an older PubMed note and Revision: v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe banner about a lapse in government funding was removed, and the page now presents the study details without that operational notice.SummaryDifference0.2%

- Check52 days agoChange DetectedNo significant changes detected on the Study Details page for NCT02034916 (ABRAZO); the core information remains consistent.SummaryDifference0.3%

- Check80 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference2%

Stay in the know with updates to ABRAZO Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABRAZO Clinical Trial page.